- Ongoing, recruitingTherapeutic exploratory (Phase II)
Orismilast for the treatment of moderate to severe ulcerative colitis
This study is looking into a new medicine called Orismilast for people in the UK with moderate to severe ulcerative colitis. It's a Phase II trial, meaning it's still in the earlier stages of testing. Researchers want to see if the medicine can help people feel better by reducing symptoms.
For: ulcerative colitisDenmark - AuthorisedTherapeutic exploratory (Phase II)
Weight management with orismilast alone or in combination with s.c. semaglutide (WELOSITI)
This study looks at a new medicine called orismilast, sometimes with semaglutide, to help adults aged 18 and over manage their weight. Researchers want to see how much weight people lose over 16 weeks.
For: obesityDenmark